Latarcin 2a

General Information


DCTPep ID  DCTPep00433

Peptide Name   Latarcin 2a

Sequence  GLFGKLIKKFGRKAISYAVKKARGKH

Sequence Length  26

UniProt ID  Q1ELU1 

PubChem CID  Not available

Origin  Central Asian spider, Lachesana tarabaevi

Type  Native peptide

Classification

  

ACP Tumor active peptide



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia EC50=3.3μM LDH leakage assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  2G9P 

Predicted Structure  DCTPep00433

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C136H229N41O29

Absent amino acids  CDEMNPQTW

Theoretical pI  11.33

Acidic residues  0

Basic residues  10

Polar residues  6

Molecular weight (Average)  2902.57

Molecular weight (Monoisotopic)  2900.77

Common amino acids  K

Net charge  10

Instability index (II)  1.29

Aliphatic index  82.69

Grand average of hydropathicity (GRAVY)  -0.438

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 1490
  Abs 0.1% (=1 g/l) 0.513

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 20887768

Title  Haemolytic and cytotoxic action of latarcin Ltc2a

Doi 10.1016/j.biochi.2010.09.016

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.